Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suvi Vaara

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Thrombosis Research|February 27, 2016
Plasma anti-FXa level as a surrogate marker of the adequacy of thromboprophylaxis in critically ill patients: A systematic reviewAnnukka Vahtera, Suvi Vaara, Ville Pettilä, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[Anticoagulation for continuous renal replacement therapy in the intensive care unit: a comparison of dalteparin infusion with regional citrate anticoagulation]Eliisa Uljas, Markku Karjalainen, Suvi Vaara, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
A good start for scientific supervisionTuomo Nieminen, Suvi Vaara, Alexey Schramko, et al.
Acta Anaesthesiologica Scandinavica|December 1, 2020
Causes of death for intensive care survivors with and without acute kidney injury in 5-year follow-upMiikka Niittyvuopio, Suvi Vaara, Pasi Ohtonen, et al.
Journal of Cardiothoracic and Vascular Anesthesia|November 19, 2016
Acute Kidney Injury After Cardiac Surgery by Complete KDIGO Criteria Predicts Increased MortalityLiisa Petäjä, Suvi Vaara, Sasu Liuhanen, et al.
Intensive Care Medicine|September 6, 2022
Delivering optimal renal replacement therapy to critically ill patients with acute kidney injuryRon Wald, William Beaubien-Souligny, Rahul Chanchlani, et al.
The New England Journal of Medicine|July 16, 2020
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury, , , et al.
Thorax|May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Thrombosis Research|February 27, 2016
Plasma anti-FXa level as a surrogate marker of the adequacy of thromboprophylaxis in critically ill patients: A systematic reviewAnnukka Vahtera, Suvi Vaara, Ville Pettilä, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[Anticoagulation for continuous renal replacement therapy in the intensive care unit: a comparison of dalteparin infusion with regional citrate anticoagulation]Eliisa Uljas, Markku Karjalainen, Suvi Vaara, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
A good start for scientific supervisionTuomo Nieminen, Suvi Vaara, Alexey Schramko, et al.
Acta Anaesthesiologica Scandinavica|December 1, 2020
Causes of death for intensive care survivors with and without acute kidney injury in 5-year follow-upMiikka Niittyvuopio, Suvi Vaara, Pasi Ohtonen, et al.
Journal of Cardiothoracic and Vascular Anesthesia|November 19, 2016
Acute Kidney Injury After Cardiac Surgery by Complete KDIGO Criteria Predicts Increased MortalityLiisa Petäjä, Suvi Vaara, Sasu Liuhanen, et al.
Intensive Care Medicine|September 6, 2022
Delivering optimal renal replacement therapy to critically ill patients with acute kidney injuryRon Wald, William Beaubien-Souligny, Rahul Chanchlani, et al.
The New England Journal of Medicine|July 16, 2020
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury, , , et al.
Thorax|May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 1